CARGO Therapeutics Inc. C...

4.64
0.00 (0.00%)
At close: Apr 17, 2025, 3:59 PM
4.64
0.00%
After-hours: Apr 17, 2025, 04:05 PM EDT

CARGO Therapeutics Common Stock Statistics

Share Statistics

CARGO Therapeutics Common Stock has 46.05M shares outstanding. The number of shares has increased by 0.42% in one year.

Shares Outstanding 46.05M
Shares Change (YoY) 0.42%
Shares Change (QoQ) 0.05%
Owned by Institutions (%) 99.99%
Shares Floating 29.81M
Failed to Deliver (FTD) Shares 5.8K
FTD / Avg. Volume 0.49%

Short Selling Information

The latest short interest is -, so null% of the outstanding shares have been sold short.

Short Interest -
Short % of Shares Out null%
Short % of Float null%
Short Ratio (days to cover) null

Valuation Ratios

The PE ratio is -3.87 and the forward PE ratio is -1.81. CARGO Therapeutics Common Stock's PEG ratio is -0.07.

PE Ratio -3.87
Forward PE -1.81
PS Ratio 0
Forward PS 0.5
PB Ratio 1.8
P/FCF Ratio -4.5
PEG Ratio -0.07
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for CARGO Therapeutics Common Stock.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.79, with a Debt / Equity ratio of 0.08.

Current Ratio 13.79
Quick Ratio 13.79
Debt / Equity 0.08
Debt / EBITDA -0.16
Debt / FCF -0.2
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-1M
Employee Count 167
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -75.6% in the last 52 weeks. The beta is 0.64, so CARGO Therapeutics Common Stock's price volatility has been higher than the market average.

Beta 0.64
52-Week Price Change -75.6%
50-Day Moving Average 3.98
200-Day Moving Average 13.74
Relative Strength Index (RSI) 59.09
Average Volume (20 Days) 1.19M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -187.37M
Net Income -167.5M
EBITDA -187.37M
EBIT n/a
Earnings Per Share (EPS) -3.72
Full Income Statement

Balance Sheet

The company has 64.38M in cash and 29.43M in debt, giving a net cash position of 34.95M.

Cash & Cash Equivalents 64.38M
Total Debt 29.43M
Net Cash 34.95M
Retained Earnings -312.65M
Total Assets 414.05M
Working Capital 319.99M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -139.74M and capital expenditures -4.45M, giving a free cash flow of -144.19M.

Operating Cash Flow -139.74M
Capital Expenditures -4.45M
Free Cash Flow -144.19M
FCF Per Share -3.21
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CRGX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for CRGX is $4, which is -14.2% lower than the current price. The consensus rating is "Hold".

Price Target $4
Price Target Difference -14.2%
Analyst Consensus Hold
Analyst Count 7
Stock Forecasts

Scores

Altman Z-Score 0.79
Piotroski F-Score 1